Picture of VIVA Biotech Holdings logo

1873 — VIVA Biotech Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapContrarian

Chief Financial Officer

Dec 1 (Reuters) - VIVA Biotech Holdings  1873.HK :
    * XIONG WEI HAS BEEN APPOINTED AS CO-CHIEF FINANCIAL OFFICER
    * REN DELIN WILL CEASE TO SERVE AS PRESIDENT OF CO

Source text for Eikon:  ID:nHKSbvq4jT 
Further company coverage:  1873.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on VIVA Biotech Holdings

See all news